Age Related Hearing Loss: Clinical Trial – Information
Autifony is sponsoring a Phase IIa age related hearing loss clinical trial in the US. Dr. Robert Frisina, Jr. is the study’s principal investigator and is director of the USF Global Center for Hearing & Speech Research. This "proof-of-concept" clinical trial will explore the potential of Autifony's lead Kv3 modulator, AUT00063, to reduce the symptoms of Age Related Hearing Loss in people who have difficulty in distinguishing speech against a background of noise.
Further information on this clinical trial is available at ClinicalTrials.gov